ERBB2 and ovarian cancer: Early relapse (<6 months) ovarian cancer overexpressing HER2, previously treated with carboplatin and paclitaxel.Chemotherapy (carboplatin and paclitaxel) alone in ­combination with Trastuzumab.Non-randomised, open-label.